Allos Therapeutics Initiates Study of PDX in Patients with …CNNMoney.com - Aug 15, 2007The cutaneous T-cells lymphomas are comprised of a number of non-Hodgkins T-cell lymphomas, including mycosis fungoides and Sezary syndrome, …Cutaneous T Cell Lymphoma Mycosis Fungoides - Google News
Read full story
Allos Therapeutics Initiates Study of PDX in Patients with …PipelineReview.com (press release), Spain - 23 hours agoThe cutaneous T-cells lymphomas are comprised of a number of non-Hodgkins T-cell lymphomas, including mycosis fungoides and Sezary syndrome, …
Read full story
Cutaneous T-Cell Lymphoma Grows More CommonMedPage Today, NJ - 10 hours ago… occurrence of cutaneous T-cell lymphoma. The cause of the "alarming" climb for this rare cancer, which includes mycosis fungoides and Sézary syndrome, …
Read full story
NCCN Updates Non-Hodgkin's Lymphoma GuidelinesPharmaLive.com (press release), PA - Jun 20, 2007The Panel also added new guidelines for Mycosis Fungoides/Sezary Syndrome (otherwise known as Cutaneous T-Cell Lymphoma (CTCL)), a disease in which certain …
Read full story
Genmab announces final humax-CD4 Phase II CTCL dataPipelineReview.com (press release), Spain - 11 hours agoClinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood 2007; 109: 4655-4662). …
Read full story
Denmark's Genmab regains rights to drug from Merck KGaAPharma Times (subscription), UK - 2 hours agoIndeed the announcement came as Genmab highlighted final data from two Phase II studies in early and late-stage mycosis fungoides (MF), a form of CTCL, …
Read full story
NCCN Updates Non-Hodgkin's Lymphoma GuidelinesGenetic Engineering News (press release), NY - Jun 20, 2007The Panel also added new guidelines for Mycosis Fungoides/Sezary Syndrome (otherwise known as Cutaneous T-Cell Lymphoma (CTCL)), a disease in which certain …
Read full story
NCCN Updates Non-Hodgkin’s Lymphoma GuidelinesBusiness Wire (press release), CA - Jun 20, 2007The Panel also added new guidelines for Mycosis Fungoides/Sezary Syndrome (otherwise known as Cutaneous T-Cell Lymphoma [CTCL]), a disease in which certain …
Read full story
Gloucester Pharmaceuticals Reports Positive Interim Phase II Data …PharmaLive.com (press release), PA - Jun 5, 2007The Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II …
Read full story
Orphan News :: Treatment & HealthCheckbiotech.org (press release), Switzerland - 1 hour agoThe Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II …
Read full story
Gloucester Pharmaceuticals Reports Positive Interim Phase II Data …Business Wire (press release), CA - 10 hours agoThe Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II …
Read full story
Cyclacel Pharmaceuticals Begins Phase II Study of Oral …PharmaLive.com (press release), PA - Apr 30, 2007Cutaneous T-cell lymphoma, or CTCL, is a cancer of a type of white blood cell called T-lymphocytes. The most common types of CTCL are mycosis fungoides and …
Read full story
Cyclacel Pharmaceuticals Begins Phase II Study of Oral …Genetic Engineering News (press release), NY - 11 hours agoCutaneous T-cell lymphoma, or CTCL, is a cancer of a type of white blood cell called T-lymphocytes. The most common types of CTCL are mycosis fungoides and …
Read full story